Immune-mediated neuroprotection of axotomized mouse facial motoneurons is dependent on the IL-4/STAT6 signaling pathway in CD4+ T cells

Cynthia A. DeBoy, Junping Xin, Susanna C. Byram, Craig J. Serpe, Virginia M. Sanders, Kathryn Jones

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

The CD4+ T lymphocyte has recently been found to promote facial motoneuron (FMN) survival after nerve injury. Signal Transducer and Activator of Transcription (STAT)4 and STAT6 are key proteins involved in the CD4+ T cell differentiation pathways leading to T helper type (Th)1 and Th2 cell development, respectively. To determine which CD4+ T cell subset mediates FMN survival, the facial nerve axotomy paradigm was applied to STAT4-deficient (-/-) and STAT6-/- mice. A significant decrease in FMN survival 4 weeks after axotomy was observed in STAT6-/- mice compared to wild-type (WT) or STAT4-/- mice. Reconstituting STAT6-/- mice with CD4+ T cells obtained from WT mice promoted WT levels of FMN survival after injury. Furthermore, rescue of FMN from axotomy-induced cell death in recombination activating gene (RAG)-2-/- mice (lacking T and B cells) could be achieved only by reconstitution with CD4+ T cells expressing functional STAT6 protein. To determine if either the Th1 cytokine, interferon-gamma (IFN-γ) or the Th2 cytokine IL-4 is involved in mediating FMN survival, facial nerve axotomy was applied to IFN-γ-/- and IL-4-/- mice. A significant decrease in FMN survival after axotomy occurred in IL-4-/- but not in IFN-γ-/- mice compared to WT mice, indicating that IL-4 but not IFN-γ is important for FMN survival after nerve injury. In WT mice, intracellular IFN-γ vs. IL-4 expression was examined in CD4+ T cells from draining cervical lymph nodes 14 days after axotomy, and substantial increase in the production of both CD4+ effector T cell subsets was found. Collectively, these data suggest that STAT6-mediated CD4+ T cell differentiation into the Th2 subset is necessary for FMN survival. A hypothesis relevant to motoneuron disease progression is presented.

Original languageEnglish (US)
Pages (from-to)212-224
Number of pages13
JournalExperimental Neurology
Volume201
Issue number1
DOIs
StatePublished - Sep 2006
Externally publishedYes

Fingerprint

Motor Neurons
Interleukin-4
Axotomy
T-Lymphocytes
Interferon-gamma
STAT6 Transcription Factor
Facial Nerve
T-Lymphocyte Subsets
Cell Differentiation
STAT4 Transcription Factor
Wounds and Injuries
Neuroprotection
Cytokines
Th2 Cells
Th1 Cells
Genetic Recombination
Disease Progression
B-Lymphocytes
Cell Death
Lymph Nodes

Keywords

  • CD4+ T lymphocyte
  • Cytokine
  • Facial nerve axotomy
  • Interferon-gamma
  • Interleukin-4
  • Motoneuron survival
  • Neuroimmune
  • T helper type 2

ASJC Scopus subject areas

  • Neurology
  • Neuroscience(all)

Cite this

Immune-mediated neuroprotection of axotomized mouse facial motoneurons is dependent on the IL-4/STAT6 signaling pathway in CD4+ T cells. / DeBoy, Cynthia A.; Xin, Junping; Byram, Susanna C.; Serpe, Craig J.; Sanders, Virginia M.; Jones, Kathryn.

In: Experimental Neurology, Vol. 201, No. 1, 09.2006, p. 212-224.

Research output: Contribution to journalArticle

DeBoy, Cynthia A. ; Xin, Junping ; Byram, Susanna C. ; Serpe, Craig J. ; Sanders, Virginia M. ; Jones, Kathryn. / Immune-mediated neuroprotection of axotomized mouse facial motoneurons is dependent on the IL-4/STAT6 signaling pathway in CD4+ T cells. In: Experimental Neurology. 2006 ; Vol. 201, No. 1. pp. 212-224.
@article{b16242ddd1494682b2613fa0405bdce4,
title = "Immune-mediated neuroprotection of axotomized mouse facial motoneurons is dependent on the IL-4/STAT6 signaling pathway in CD4+ T cells",
abstract = "The CD4+ T lymphocyte has recently been found to promote facial motoneuron (FMN) survival after nerve injury. Signal Transducer and Activator of Transcription (STAT)4 and STAT6 are key proteins involved in the CD4+ T cell differentiation pathways leading to T helper type (Th)1 and Th2 cell development, respectively. To determine which CD4+ T cell subset mediates FMN survival, the facial nerve axotomy paradigm was applied to STAT4-deficient (-/-) and STAT6-/- mice. A significant decrease in FMN survival 4 weeks after axotomy was observed in STAT6-/- mice compared to wild-type (WT) or STAT4-/- mice. Reconstituting STAT6-/- mice with CD4+ T cells obtained from WT mice promoted WT levels of FMN survival after injury. Furthermore, rescue of FMN from axotomy-induced cell death in recombination activating gene (RAG)-2-/- mice (lacking T and B cells) could be achieved only by reconstitution with CD4+ T cells expressing functional STAT6 protein. To determine if either the Th1 cytokine, interferon-gamma (IFN-γ) or the Th2 cytokine IL-4 is involved in mediating FMN survival, facial nerve axotomy was applied to IFN-γ-/- and IL-4-/- mice. A significant decrease in FMN survival after axotomy occurred in IL-4-/- but not in IFN-γ-/- mice compared to WT mice, indicating that IL-4 but not IFN-γ is important for FMN survival after nerve injury. In WT mice, intracellular IFN-γ vs. IL-4 expression was examined in CD4+ T cells from draining cervical lymph nodes 14 days after axotomy, and substantial increase in the production of both CD4+ effector T cell subsets was found. Collectively, these data suggest that STAT6-mediated CD4+ T cell differentiation into the Th2 subset is necessary for FMN survival. A hypothesis relevant to motoneuron disease progression is presented.",
keywords = "CD4+ T lymphocyte, Cytokine, Facial nerve axotomy, Interferon-gamma, Interleukin-4, Motoneuron survival, Neuroimmune, T helper type 2",
author = "DeBoy, {Cynthia A.} and Junping Xin and Byram, {Susanna C.} and Serpe, {Craig J.} and Sanders, {Virginia M.} and Kathryn Jones",
year = "2006",
month = "9",
doi = "10.1016/j.expneurol.2006.04.028",
language = "English (US)",
volume = "201",
pages = "212--224",
journal = "Experimental Neurology",
issn = "0014-4886",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Immune-mediated neuroprotection of axotomized mouse facial motoneurons is dependent on the IL-4/STAT6 signaling pathway in CD4+ T cells

AU - DeBoy, Cynthia A.

AU - Xin, Junping

AU - Byram, Susanna C.

AU - Serpe, Craig J.

AU - Sanders, Virginia M.

AU - Jones, Kathryn

PY - 2006/9

Y1 - 2006/9

N2 - The CD4+ T lymphocyte has recently been found to promote facial motoneuron (FMN) survival after nerve injury. Signal Transducer and Activator of Transcription (STAT)4 and STAT6 are key proteins involved in the CD4+ T cell differentiation pathways leading to T helper type (Th)1 and Th2 cell development, respectively. To determine which CD4+ T cell subset mediates FMN survival, the facial nerve axotomy paradigm was applied to STAT4-deficient (-/-) and STAT6-/- mice. A significant decrease in FMN survival 4 weeks after axotomy was observed in STAT6-/- mice compared to wild-type (WT) or STAT4-/- mice. Reconstituting STAT6-/- mice with CD4+ T cells obtained from WT mice promoted WT levels of FMN survival after injury. Furthermore, rescue of FMN from axotomy-induced cell death in recombination activating gene (RAG)-2-/- mice (lacking T and B cells) could be achieved only by reconstitution with CD4+ T cells expressing functional STAT6 protein. To determine if either the Th1 cytokine, interferon-gamma (IFN-γ) or the Th2 cytokine IL-4 is involved in mediating FMN survival, facial nerve axotomy was applied to IFN-γ-/- and IL-4-/- mice. A significant decrease in FMN survival after axotomy occurred in IL-4-/- but not in IFN-γ-/- mice compared to WT mice, indicating that IL-4 but not IFN-γ is important for FMN survival after nerve injury. In WT mice, intracellular IFN-γ vs. IL-4 expression was examined in CD4+ T cells from draining cervical lymph nodes 14 days after axotomy, and substantial increase in the production of both CD4+ effector T cell subsets was found. Collectively, these data suggest that STAT6-mediated CD4+ T cell differentiation into the Th2 subset is necessary for FMN survival. A hypothesis relevant to motoneuron disease progression is presented.

AB - The CD4+ T lymphocyte has recently been found to promote facial motoneuron (FMN) survival after nerve injury. Signal Transducer and Activator of Transcription (STAT)4 and STAT6 are key proteins involved in the CD4+ T cell differentiation pathways leading to T helper type (Th)1 and Th2 cell development, respectively. To determine which CD4+ T cell subset mediates FMN survival, the facial nerve axotomy paradigm was applied to STAT4-deficient (-/-) and STAT6-/- mice. A significant decrease in FMN survival 4 weeks after axotomy was observed in STAT6-/- mice compared to wild-type (WT) or STAT4-/- mice. Reconstituting STAT6-/- mice with CD4+ T cells obtained from WT mice promoted WT levels of FMN survival after injury. Furthermore, rescue of FMN from axotomy-induced cell death in recombination activating gene (RAG)-2-/- mice (lacking T and B cells) could be achieved only by reconstitution with CD4+ T cells expressing functional STAT6 protein. To determine if either the Th1 cytokine, interferon-gamma (IFN-γ) or the Th2 cytokine IL-4 is involved in mediating FMN survival, facial nerve axotomy was applied to IFN-γ-/- and IL-4-/- mice. A significant decrease in FMN survival after axotomy occurred in IL-4-/- but not in IFN-γ-/- mice compared to WT mice, indicating that IL-4 but not IFN-γ is important for FMN survival after nerve injury. In WT mice, intracellular IFN-γ vs. IL-4 expression was examined in CD4+ T cells from draining cervical lymph nodes 14 days after axotomy, and substantial increase in the production of both CD4+ effector T cell subsets was found. Collectively, these data suggest that STAT6-mediated CD4+ T cell differentiation into the Th2 subset is necessary for FMN survival. A hypothesis relevant to motoneuron disease progression is presented.

KW - CD4+ T lymphocyte

KW - Cytokine

KW - Facial nerve axotomy

KW - Interferon-gamma

KW - Interleukin-4

KW - Motoneuron survival

KW - Neuroimmune

KW - T helper type 2

UR - http://www.scopus.com/inward/record.url?scp=33747120224&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33747120224&partnerID=8YFLogxK

U2 - 10.1016/j.expneurol.2006.04.028

DO - 10.1016/j.expneurol.2006.04.028

M3 - Article

C2 - 16806176

AN - SCOPUS:33747120224

VL - 201

SP - 212

EP - 224

JO - Experimental Neurology

JF - Experimental Neurology

SN - 0014-4886

IS - 1

ER -